Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin αIIbβ3

被引:88
作者
Puzon-McLaughlin, W [1 ]
Kamata, T [1 ]
Takada, Y [1 ]
机构
[1] Scripps Res Inst, Dept Vasc Biol, CAL 10, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.275.11.7795
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integrin alpha(IIb)beta(3), a platelet fibrinogen receptor, is critically involved in thrombosis and hemostasis. However, how ligands interact with alpha(IIb)beta(3) has been controversial, Ligand-mimetic anti-alpha(IIb)beta(3) antibodies (PAC-1, LJ-CP3, and OP-G2) contain the RGD-like RYD sequence in their CDR3 in the heavy chain and have structural and functional similarities to native ligands. We have located binding sites for ligand-mimetic antibodies in alpha(IIb) and beta(3) using human-to-mouse chimeras, which we expect to maintain functional integrity of alpha(IIb)beta(3). Here we report that these antibodies recognize several discontinuous binding sites;in both the alpha(IIb) and beta(3) subunits; these binding sites are located in residues 156-162 and 229-230 of alpha(IIb) and residues 179-183 of beta(3). In contrast, several nonligand-mimetic antibodies (e.g. 7E3) recognize single epitopes in either subunit, Thus, binding to several discontinuous sites in both subunits is unique to ligand-mimetic antibodies. Interestingly, these binding sites overlap with several (but not all) of the sequences that have been reported to be critical for fibrinogen binding (e.g. N-terminal repeats 2-3 but not repeats 4-7, of alpha(IIb)). These results suggest that ligand-mimetic antibodies and probably native ligands may make direct contact with these discontinuous binding sites in both subunits, which may constitute a ligand-binding pocket.
引用
收藏
页码:7795 / 7802
页数:8
相关论文
共 52 条
  • [1] BAJT ML, 1994, J BIOL CHEM, V269, P20913
  • [2] INHIBITION OF FIBRINOGEN BINDING TO STIMULATED HUMAN-PLATELETS BY A MONOCLONAL-ANTIBODY
    BENNETT, JS
    HOXIE, JA
    LEITMAN, SF
    VILAIRE, G
    CINES, DB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09): : 2417 - 2421
  • [3] CHARO IF, 1991, J BIOL CHEM, V266, P1415
  • [4] A NOVEL VITRONECTIN RECEPTOR INTEGRIN (ALPHA-V-BETA-X) IS RESPONSIBLE FOR DISTINCT ADHESIVE PROPERTIES OF CARCINOMA-CELLS
    CHERESH, DA
    SMITH, JW
    COOPER, HM
    QUARANTA, V
    [J]. CELL, 1989, 57 (01) : 59 - 69
  • [5] Peptide ligands can bind to distinct sites in integrin αIIbβ3 and elicit different functional responses
    Cierniewski, CS
    Byzova, T
    Papierak, M
    Haas, TA
    Niewiarowska, J
    Zhang, L
    Cieslak, M
    Plow, EF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) : 16923 - 16932
  • [6] A NEW MURINE MONOCLONAL-ANTIBODY REPORTS AN ACTIVATION-DEPENDENT CHANGE IN THE CONFORMATION AND OR MICROENVIRONMENT OF THE PLATELET GLYCOPROTEIN IIB/IIIA COMPLEX
    COLLER, BS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) : 101 - 108
  • [7] BINDING OF GLYCOPROTEIN-IIIA-DERIVED PEPTIDE-217-231 TO FIBRINOGEN AND VONWILLEBRAND-FACTORS AND ITS INHIBITION BY PLATELET GLYCOPROTEIN-IIB/IIIA COMPLEX
    COOK, JJ
    TRYBULEC, M
    LASZ, EC
    KHAN, S
    NIEWIAROWSKI, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1119 (03) : 312 - 321
  • [8] AN ECHISTATIN-LIKE ARG-GLY-ASP (RGD)-CONTAINING SEQUENCE IN THE HEAVY-CHAIN CDR3 OF A MURINE MONOCLONAL-ANTIBODY THAT INHIBITS HUMAN PLATELET GLYCOPROTEIN IIB/IIIA FUNCTION
    DECKMYN, H
    STANSSENS, P
    HOET, B
    DECLERCK, PJ
    LAUWEREYS, M
    GANSEMANS, Y
    TORNAI, I
    VERMYLEN, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (03) : 562 - 571
  • [9] SITE-DIRECTED MUTAGENESIS OF VIRTUALLY ANY PLASMID BY ELIMINATING A UNIQUE SITE
    DENG, WP
    NICKOLOFF, JA
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 200 (01) : 81 - 88
  • [10] A DISCRETE SEQUENCE IN A PLATELET INTEGRIN IS INVOLVED IN LIGAND RECOGNITION
    DSOUZA, SE
    GINSBERG, MH
    MATSUEDA, GR
    PLOW, EF
    [J]. NATURE, 1991, 350 (6313) : 66 - 68